HSP90AA1 and neoplasm: Out of the 5/30 (17%) brain metastases with lower HSP90 than the corresponding primary tumor, 3/5 (60%) cases still remained within the HSP90high category and only 2/5 (40%) switched from HSP90high to HSP90low (Fig 3I).